#CIPLA
#Markets: Broader markets also ended lower, with the Nifty Midcap index falling 1.2%, while the Smallcap index declined 0.35%.
www.newsinc24.com/news/sensex-...
Sensex fall 500 pts, Nifty below 25,250 amid selling pressure
SBI, Cipla, Tata Consumer Products, ITC and Apollo Hospitals were the top gainers on the Nifty
www.newsinc24.com
November 18, 2026 at 11:39 AM
Why Indian drugmakers are losing pricing power in the US

Revlimid cliff Generic Revlimid, or lenalidomide, a blood cancer drug, was a high-margin US product for Indian drugmakers until early 2026. Under patent settlements with the brand's owner, several companies, including Dr. Reddy's, Cipla,…
Why Indian drugmakers are losing pricing power in the US
Revlimid cliff Generic Revlimid, or lenalidomide, a blood cancer drug, was a high-margin US product for Indian drugmakers until early 2026. Under patent settlements with the brand's owner, several companies, including Dr. Reddy's, Cipla, Zydus and Aurobindo, began selling limited volumes in 2022. These volume restrictions ended on 31 January 2026, paving the way for new manufacturers, including Intas's Accord Healthcare. Source link
freeaitoolsayoob.com
November 17, 2026 at 10:07 AM
The bevacizumab biosimilars market is projected to grow from $1.64 billion in 2025 to $2.42 billion by 2030, driven by rising cancer cases, increasing demand for affordable biologic therapies, and advancements in biotechnology and drug development.
thebusinessresearchcompany.com/report/bevac...
Bevacizumab Biosimilars Market Size, Forecast Report 2026-2030
Bevacizumab Biosimilars market size reached $1.77 billion in 2026 and is expected to grow to $2.42 billion by 2030 at a 8.2% CAGR. Major players: Cipla Limited, Reliance lifesciences Pvt. Ltd., Fujifi...
thebusinessresearchcompany.com
November 12, 2026 at 12:07 PM
Sun Pharma vs Cipla vs Dr Reddy's: who is really winning? Margins and US sales compared. 10-min video:
https://youtu.be/pIp63_D-3QU
#Pharma #SunPharma #Cipla #MarketResearch #B2B #GlobalBusiness
Sun Pharma vs Cipla vs Dr Reddy's: Who Is Really Winning? (Margins and US Sales Explained)
Cipla's profit fell 35% and Dr Reddy's fell 36% in Q2 FY27 as North...
youtu.be
November 1, 2026 at 4:56 AM
What's next for #IPpolicy in Washington?

On 11/5, C4IP Pres. & CEO Coke Morgan Stewart will take the stage at the University of Akron to discuss the latest developments at the #USPTO, #patent eligibility and enforcement, and proposals under consideration to strengthen #IP rights.

Register here:
The Cleveland Intellectual Property Law Association - November 2026 CIPLA Meeting
www.cipla.org
November 2, 2026 at 3:09 PM
Cipla: Q2 FY27 Results Analysis

Cipla: Q2 profit down about 35% to Rs 851 to 878 Cr on North America pressure. Turnaround phase.
Cipla: Q2 FY27 Results Analysis
Cipla: Q2 profit down about 35% to Rs 851 to 878 Cr on North America pressure. Turnaround phase.
convictioncaution.com
October 29, 2026 at 6:45 AM
Fosfomycin Tromethamine Granules for Oral Solution recall: Cipla USA, Inc., Class II (FDA event 99930)

https://recallregister.com/fda/ii/99930/
October 28, 2026 at 7:50 PM
On 11/5, C4IP Pres. & CEO Coke Morgan Stewart will give a keynote address at the University of Akron on the current state of #IPpolicy in Washington.

She'll discuss the latest developments at the #USPTO, #patent eligibility and enforcement, and proposals under consideration to strengthen #IPrights.
The Cleveland Intellectual Property Law Association - November 2026 CIPLA Meeting
www.cipla.org
October 28, 2026 at 8:06 PM
⚠️ NSE:CIPLA Cipla/Margin Compression: EBITDA margin down ~630 bps YoY to 18.7% while employee costs rose ~12% against a ~2% revenue decline; other operating income fell ~75% to Rs 36 Cr [HIGH RISK]
October 27, 2026 at 3:35 PM
FMCG and media stocks took the biggest hit while Bajaj Finance and Cipla tried to keep the lights on.
October 23, 2026 at 5:37 AM
Cipla Limited — Market Update

Cipla Limited disclosed that the USFDA conducted a routine current Good Manufacturing Practices (cGMP) inspection at the Hauppauge, Long Island, New York facility of InvaGen Pharmaceuticals Inc., its wholly owned subsidiary, from 19 to 22 October 2026...

🧵 continued ↓
October 23, 2026 at 4:15 AM
#Market: The broader markets continued to underperform the benchmark indices, with the Nifty Midcap and Smallcap indices declining around 1 percent each.
www.newsinc24.com/news/sensex-...
Sensex fall 460 pts, Nifty below 22,700 amid elevated oil prices
Bajaj Finance, Cipla, SBI, Bajaj Auto and ICICI Bank were the top gainers on the Nifty
www.newsinc24.com
October 22, 2026 at 12:21 PM
from india. the generic is $4 a month the generic, made by cipla.
October 21, 2026 at 12:13 AM
BTST / STBT WATCHLIST · 19 OCTOBER 2026 MONDAY

BTST: Bankbaroda, Bankindia, Mtartech
STBT: Mankind, Sbicard, Cipla

For learning only, not a recommendation.

#BANKBARODA #BANKINDIA #MTARTECH #MANKIND #SBICARD #CIPLA #BTST #STBT
October 19, 2026 at 9:50 AM
Cipla and Qilu Announce Exclusive U.S. Licensing and Supply Agreement for Pembrolizumab Biosimilar
Cipla and Qilu Announce Exclusive U.S. Licensing and Supply Agreement for Pembrolizumab Biosimilar
On September 3, 2026, InvaGen Pharmaceuticals Inc., a wholly owned subsidiary of Cipla Limited, announced a strategic partnership and exclusive...
www.jdsupra.com
September 16, 2026 at 4:43 PM
Cipla and Qilu Announce Exclusive U.S. Licensing and Supply Agreement for Pembrolizumab Biosimilar
Cipla and Qilu Announce Exclusive U.S. Licensing and Supply Agreement for Pembrolizumab Biosimilar
On September 3, 2026, InvaGen Pharmaceuticals Inc., a wholly owned subsidiary of Cipla Limited, announced a strategic partnership and exclusive...
www.jdsupra.com
September 16, 2026 at 4:43 PM
Fullform 200 Rotacap – Combination Therapy for Breathing Conditions

Fullform 200 Rotacap combines beclometasone 200 mcg with formoterol 6 mcg. This inhaled combination is prescribed for controlling respiratory conditions such as asthma and COPD.
Buy now: edpillsforever.com/product/full...
Beclomethasone Formoterol | Fullform Rotacaps 200 Mcg, Cipla
Beclomethasone Formoterol (Fullform Rotacaps 200 mcg) by Cipla. Treats asthma & COPD. 3–9 inhalers from $124.22. In Stock. Fast & discreet worldwide shipping.
edpillsforever.com
September 11, 2026 at 9:01 AM
Big Daddy laps up Cipla after Q1 nos beat forecast

Shares of Cipla inched up on heavy volumes on Friday, after the companys first quarter earnings beat the consensus estimate.
September 10, 2026 at 12:10 AM
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar reut.rs/3Uz8x1Y
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
India's Cipla said on Thursday its U.S. unit entered an ​exclusive partnership with China's Qilu Pharmaceutical ‌to license a biosimilar version of Merck's cancer drug Keytruda for the U.S. ​market.
reut.rs
September 3, 2026 at 7:10 PM
Theo Asthalin Forte 4 mg/200 mg: Uses, Dosage, and Safety Information

Theo Asthalin Forte 4 mg/200 mg is a respiratory medicine prescribed for certain airway conditions that can cause breathing difficulty, wheezing, or chest tightness.
Buy now: edpillsforever.com/product/theo...
Buy Theo Asthalin Forte 4 Mg+200 Mg Online | Best Price
Order Theo Asthalin Forte 4 mg+200 mg by Cipla – trusted bronchodilator for Asthma & COPD. Salbutamol + Theophylline combo. Prices from $6. Secure checkout.
edpillsforever.com
September 4, 2026 at 6:52 AM